Delcath Systems Inc. (NASDAQ: DCTH) announced that results from the CHOPIN Phase 2 clinical trial have been published in The ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE